Market Place
Sourcing Support
All News #Library
Biotech
Basilea Shareholders Endorse Board Proposals At 2026 AGM
15 Apr 2026 //
GLOBENEWSWIRE
Basilea Secures $6M CARB-X Funding For Antibiotic BAL2420
09 Apr 2026 //
GLOBENEWSWIRE
Basilea Initiates First Human Study Of Antibiotic BAL2420
23 Mar 2026 //
GLOBENEWSWIRE
Basilea Reports Strong 2025 Full-Year Results, Profit Guidance
17 Feb 2026 //
GLOBENEWSWIRE
Basilea Receives Milestone Payment For Cresemba Sales In Asia
09 Feb 2026 //
GLOBENEWSWIRE
Basilea Joins INCATE To Support Antifungal Innovation
13 Jan 2026 //
GLOBENEWSWIRE
Basilea Pens Collab With US Biotech To Develop Antifungal
07 Jan 2026 //
FIERCE BIOTECH
Phare Bio, Basilea Partner to Develop AI-Driven Antibiotic
11 Dec 2025 //
BUSINESSWIRE
Basilea Secures BARDA Contract For Ceftibuten-Ledaborbactam
25 Sep 2025 //
GLOBENEWSWIRE
Basilea secures $25M BARDA funding for antifungals Fosmanogepix
16 Sep 2025 //
GLOBENEWSWIRE
Basilea Gains $39M from BARDA`s Antifungal Funding Plan
08 Jul 2025 //
FIERCE BIOTECH
Basilea Partners With Glioblastoma Foundation For Lisavanbulin Development
20 Jun 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.